Navigation Links
Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
Date:8/19/2007

unding on favorable terms, continued operating losses and the inability to continue operations as a result, and a variety of other risks set forth from time to time in Vion's filings with the Securities and Exchange Commission, including but not limited to the risks attendant to the forward-looking statements included under Item 1A, "Risk Factors" in Vion's Annual Report on Form 10-K for the year ended December 31, 2006 and the Company's Form 10-Q for the quarter ended June 30, 2007. In particular, there can be no assurance as to the results of any of the Company's clinical trials, that any of these trials will continue to full accrual, or that any of these trials will not be discontinued, modified, delayed or ceased altogether. Except in special circumstances in which a duty to update arises under law when prior disclosure becomes materially misleading in light of subsequent events, Vion does not intend to update any of these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

COMPANY CONTACT: Vion Pharmaceuticals, Inc.

Alan Kessman, Chief Executive Officer

Howard B. Johnson, President & CFO

(203) 498-4210


'/>"/>
SOURCE Vion Pharmaceuticals, Inc.

Copyright©2007 PR Newswire.

Page: 1 2 3 4

Related medicine technology :

1. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
6. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
7. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
8. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple Myeloma and Waldenstroms Macroglobulinemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... , July 30, 2015  OncoGenex Pharmaceuticals, Inc. ... report its second quarter 2015 financial results on Thursday, ... call and live webcast at 4:30 p.m. Eastern Time ... programs and a general corporate update. ... Relations page of the OncoGenex website at www.oncogenex.com ...
(Date:7/30/2015)... , July 30, 2015 Tianyin Pharmaceutical Inc. ... company that specializes in the patented biopharmaceutical, modernized traditional ... (API), provided updates regarding the notice it received on ... "Exchange") indicating that the Company was below certain of ... Sections 134 and 1101 of the NYSE MKT Company ...
(Date:7/30/2015)... 30, 2015 Future Market Insights ... "Continuous Glucose Monitoring Systems Market: Global Industry Analysis and ... the global continuous glucose monitoring systems market was valued ... to reach US$ 788.4 Mn by 2020, registering a ... 2020. Global continuous glucose monitoring systems market ...
Breaking Medicine Technology:TPI Provides Update Regarding Non-Compliance with NYSE MKT Continued Listing Requirements 2Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 2Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 3Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 4
... Bulletin Board: WDST ), a clinical-stage company developing ... human skin, will present at the Rodman & Renshaw Healthcare ... City from September 12-15, 2010. Regenicin™ President Joe ... EDT to provide a status update on the company,s Pipeline ...
... OMAHA, Neb., Sept. 8 Transgenomic, Inc. (OTC Bulletin ... Tuttle, president and chief executive officer, will deliver the ... Annual Global Investment Conference on Monday, September 13 at ... the Palace Hotel in New York City from September ...
Cached Medicine Technology:Regenicin™ to Present at the Rodman & Renshaw Healthcare Conference 2Transgenomic to Present at the Rodman & Renshaw 12th Annual Global Investment Conference 2Transgenomic to Present at the Rodman & Renshaw 12th Annual Global Investment Conference 3
(Date:7/31/2015)... , ... August 01, 2015 , ... Super Bowl 50 will emanate from ... League’s biggest day each year is the Super Bowl. In the two weeks that separate ... from the host venue. The 2016 Super Bowl game will mark the 50th time it ...
(Date:7/31/2015)... ... ... The 2nd annual Ride to Fight On will start and end near the ... to Fight On is a cycling fundraiser that benefits the West Cancer Center, a ... University of Tennessee Health Science Center. A health and wellness festival featuring food, music, ...
(Date:7/31/2015)... Mountain View, CA (PRWEB) , ... July 31, 2015 , ... ... hand for the athletes, judges, media, and VIPs at the 2015 Vans US Open ... best-tasting organic coconut water that can claim “no added sugar” on the market, is ...
(Date:7/31/2015)... ... July 31, 2015 , ... Well-known for its unique pastries ... wedding cakes with custom designs, making life just a little bit sweeter for ... cakes for each customer who orders one. , The bakery provides a full line ...
(Date:7/31/2015)... ... July 31, 2015 , ... Transfinder, a software company based in ... were up 16 percent year-over-year for the first six months ended June 30, 2015 ... expected Transfinder to beat last year’s record-revenue mark of $10.4 million. , “We know ...
Breaking Medicine News(10 mins):Health News:Cheap 2016 Super Bowl Tickets at Levi's Stadium: Ticket Down Slashes Ticket Prices on Super Bowl 50 Tickets in Santa Clara, CA at Levi's Stadium 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 3Health News:Coco Libre Brings Eco-conscious Hydration to Vans US Open of Surfing 2Health News:Pastry Palace of Las Vegas Announces It Is Now Offering Custom Wedding Cakes in Las Vegas 2Health News:Transfinder Closes First Half of 2015 with Record Revenue 2
... Soldiers Now Have New Weapon against Chronic Migraines from ... PHP announced today that it is making its new ... service in Iraq and Afghanistan. According to published reports, ... duty in the Middle East are suffering from migraines ...
... DAVID COOK,S ,IDOL, PERFORMANCE WILL BE SOLD ON iTUNES ... Live Version of ,Permanent, Will Be Donated To D.C.-Based ... one year after winning the seventh season of "American ... series in America on Wednesday night to perform "Permanent," ...
... can be a very complicated issue and quite often families ... right questions to ask when they start -- or when ... Philanthropies is adding a new series to its ... ANSWER... "About Long-term Care. This new series will provide ...
... CARROLLTON, Texas, May 20 The Indiana ... representing most of that state,s podiatrists, today ... A-Claim(TM) medical payment solution for physicians, hospitals ... endorsement, the IPMA signed a three-year agreement ...
... at the Helmholtz Centre for Infection Research (HZI) in ... for the first time that bacteria of the ... the protein RovA - which assists them in the ... both the temperature of its host as well as ...
... of May 1st, 2009 in TEDA Tianjin, ChinaTEDA Tianjin, ... research-based contract manufacturer of API,s and intermediates, and Drug ... the opening if its high potency Active Pharmaceutical Ingredient ... This dedicated facility is sited at Asymchem,s TEDA ...
Cached Medicine News:Health News:Clinical Topicals Makes Breakthrough Migraine Treatment Available Free to Soldiers 2Health News:David Cook to Perform 'Permanent' on the American Idol Season Finale Tonight 2Health News:Heinz Family Philanthropies (www.heinzfamily.org) Release Questions Families Should Ask About Long-Term Care - 10 Questions to Answer...(www.tenquestionstoanswer.org) 2Health News:Heinz Family Philanthropies (www.heinzfamily.org) Release Questions Families Should Ask About Long-Term Care - 10 Questions to Answer...(www.tenquestionstoanswer.org) 3Health News:Indiana Podiatric Medical Association Endorses A-Claim Payment Solution 2Health News:Bacteria with a built-in thermometer 2Health News:Asymchem Announces Opening of High Potency API and Drug Product Facility 2
All Purpose, General Procedure Apron...
The Velcro Apron provides .50mm Pb protection with the added ease of velcro closures. This form-fitting apron offers comfort and protection while at the same time allowing for easy-on/easy-off access...
... apron has the same ... as the standard Cool-Tech™ ... with velcro fasteners at ... as side flaps for ...
Apron,special Proceddure...
Medicine Products: